Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
334 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in United StatesImproving Delivery of Aging-Related Supportive Care for Older Adults With Acute Myeloid Leukemia
- Where
- Birmingham
- Age
- 18 years and over
- People
- 40
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07777471 - No phaseTaking peopleLongitudinal Studies of Patient With FPDMM
- Where
- Bethesda
- Age
- 1 day to 100 years
- People
- 1,000
- Run by
- National Human Genome Research Institute (NHGRI)
See details and how to joinNCT03854318 - Phase 1/2Taking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Atlanta, Aurora, Boston, Chicago, Cincinnati, Columbus, Duarte, Durham, Hackensack, Houston, Iowa City, Los Angeles, New York, Palo Alto, Philadelphia, Portland, Salt Lake City, Sarasota, St Louis, Tampa
- Age
- 30 days and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - Phase 1Taking peopleDecitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission
- Where
- Houston
- Age
- 18 years and over
- People
- 125
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05010772 - Phase 1Taking peopleZiftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia
- Where
- Atlanta, Aurora, Boston, Chicago, Cincinnati, Houston, Los Angeles, Memphis, New York, Philadelphia, Seattle
- Age
- 0 years to 21 years
- People
- 20 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT06376162 · EU 2023-505262-28-00 - Phase 1Taking peopleA Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
- Where
- Houston, Tampa
- Age
- 18 years and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06616636 - No phaseTaking peopleA Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
- Where
- Bethesda, Charlotte, Cincinnati, Columbus, Fargo, Iowa City, Maumee, Reno, Rochester, Sioux Falls, St Louis, York
- Age
- 0 years and over
- People
- 550
- Run by
- Tempus AI
See details and how to joinNCT07154823 - Phase 2Not yet taking people in United StatesPhase II De-Escalation Study of Metronomic Decitabine/Cedazuridine Plus Venetoclax in AML
- Where
- New Brunswick
- Age
- 18 years and over
- People
- 41
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT07867626 - Phase 1/2Taking peopleDecitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
- Where
- Cleveland
- Age
- 18 years and over
- People
- 20
- Run by
- Benjamin Tomlinson
See details and how to joinNCT06129734 - Phase 2Taking peopleEfficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker
- Where
- Houston
- Age
- 18 years and over
- People
- 112
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT07060001 - Phase 1Taking peopleZiftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML
- Where
- Boston
- Age
- 12 years and over
- People
- 24
- Run by
- Massachusetts General Hospital
See details and how to joinNCT07355335 - Phase 2Taking peopleTotal Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
- Where
- Duarte
- Age
- 18 years and over
- People
- 35
- Run by
- City of Hope Medical Center
See details and how to joinNCT07582172 - Phase 2Taking peopleFludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 270
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT00801489 - Phase 1/2Taking peopleAzacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- Where
- Houston
- Age
- 18 years and over
- People
- 97
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04140487 - Phase 2/3Taking peopleA Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Where
- Atlanta, Boston, Buffalo, Charleston, Columbus, Dallas, Durham, Hackensack, Houston, Los Angeles, Miami, Milwaukee, Mineola, Nashville, New Haven, New York, Orange, Portland, Salem, Seattle, The Bronx
- Age
- 18 years and over
- People
- 316 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04256317 · EU 2024-515098-93-00 - Phase 1Taking peopleA Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 1 year and over
- People
- 15
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06017258 - Phase 1Taking peopleZiftomenib Maintenance Post Allo-HCT
- Where
- Boston, Columbus
- Age
- 18 years and over
- People
- 22
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06440135 - Phase 2Taking peopleMonitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study
- Where
- Houston
- Age
- 18 years and over
- People
- 140
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06811233 - Phase 2Taking peopleA Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 60 years and over
- People
- 45
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07392242 - No phaseTaking peopleIndividualized AML Treatment
- Where
- Duarte
- Age
- 18 years and over
- People
- 20
- Run by
- City of Hope Medical Center
See details and how to joinNCT07613385 - Phase 2Taking peopleVenetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- Where
- Houston
- Age
- 50 years and over
- People
- 145
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03586609 - Early phase 1Taking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Age
- 18 years and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - Phase 2Taking peopleIvosidenib as Post-HSCT Maintenance for AML
- Where
- Atlanta, Boston, Columbus, Kansas City, Milwaukee, Salt Lake City
- Age
- 18 years to 75 years
- People
- 75
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06707493 - Phase 1Taking peopleA Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Atlanta, Dallas, Nashville, Palo Alto, Valhalla
- Age
- 6 months to 17 years
- People
- 18 worldwide
- Run by
- AbbVie
See details and how to joinNCT07306832 - Phase 1Taking peopleRuxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
- Where
- Portland
- Age
- 18 years and over
- People
- 40
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT07548983